Pro-Dex, Inc. (PDEX)
58.10
-3.50
(-5.68%)
USD |
NASDAQ |
Oct 30, 16:00
58.16
+0.06
(+0.10%)
After-Hours: 20:00
Pro-Dex Enterprise Value : 205.86M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 205.86M |
| October 28, 2026 | 210.93M |
| October 27, 2026 | 208.00M |
| October 26, 2026 | 202.87M |
| October 23, 2026 | 207.84M |
| October 22, 2026 | 208.35M |
| October 21, 2026 | 202.55M |
| October 20, 2026 | 198.84M |
| October 19, 2026 | 193.44M |
| October 16, 2026 | 195.22M |
| October 15, 2026 | 200.83M |
| October 14, 2026 | 200.19M |
| October 13, 2026 | 208.00M |
| October 12, 2026 | 210.61M |
| October 09, 2026 | 208.70M |
| October 08, 2026 | 207.81M |
| October 07, 2026 | 209.69M |
| October 06, 2026 | 216.44M |
| October 05, 2026 | 217.99M |
| October 02, 2026 | 213.73M |
| October 01, 2026 | 217.84M |
| September 30, 2026 | 229.44M |
| September 29, 2026 | 232.69M |
| September 28, 2026 | 237.79M |
| September 25, 2026 | 238.27M |
| Date | Value |
|---|---|
| September 24, 2026 | 242.25M |
| September 23, 2026 | 238.81M |
| September 22, 2026 | 240.31M |
| September 21, 2026 | 240.66M |
| September 18, 2026 | 240.75M |
| September 17, 2026 | 230.95M |
| September 16, 2026 | 238.52M |
| September 15, 2026 | 222.78M |
| September 14, 2026 | 221.67M |
| September 11, 2026 | 209.70M |
| September 10, 2026 | 200.26M |
| September 09, 2026 | 203.00M |
| September 08, 2026 | 221.19M |
| September 04, 2026 | 243.49M |
| September 03, 2026 | 206.34M |
| September 02, 2026 | 208.99M |
| September 01, 2026 | 205.23M |
| August 31, 2026 | 207.46M |
| August 28, 2026 | 208.91M |
| August 27, 2026 | 216.25M |
| August 26, 2026 | 213.00M |
| August 25, 2026 | 217.40M |
| August 24, 2026 | 222.62M |
| August 21, 2026 | 218.83M |
| August 20, 2026 | 220.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 69.97B |
| Abbott Laboratories | 208.60B |
| AngioDynamics, Inc. | 500.71M |
| Alphatec Holdings, Inc. | 2.245B |
| AtriCure, Inc. | 3.084B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.857M |
| Revenue (Quarterly) | 20.40M |
| Total Expenses (Quarterly) | 17.55M |
| EPS Diluted (Quarterly) | 0.8672 |
| Gross Profit Margin (Quarterly) | 34.75% |
| Profit Margin (Quarterly) | 14.00% |
| Earnings Yield | 7.12% |
| Operating Earnings Yield | 6.77% |
| Normalized Earnings Yield | 5.927 |